Outcome of Later-Onset Pompe Disease Identified Through Newborn Screening

NI-CHUNG LEEChang, Kai-LingKai-LingChangIn 't Groen, Stijn L MStijn L MIn 't Groende Faria, Douglas O SDouglas O Sde FariaHuang, Hsiang-JuHsiang-JuHuangPijnappel, W W M PimW W M PimPijnappelWUH-LIANG HWUYIN-HSIU CHIEN2022-03-092022-03-092022-01-0400223476https://scholars.lib.ntu.edu.tw/handle/123456789/596901To determine the outcomes of patients with later-onset Pompe disease (LOPD) identified through newborn screening (NBS).enenzyme replacement therapy; genetic variations; glycogen storage disease type II; hypotonia; manifestation–neuromuscular[SDGs]SDG3Outcome of Later-Onset Pompe Disease Identified Through Newborn Screeningjournal article10.1016/j.jpeds.2021.12.072349956422-s2.0-85123706310https://scholars.lib.ntu.edu.tw/handle/123456789/594404